Related news for:   Professor Maher Gandhi

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

04

Sep

Mater Research CEO appointed to new National Blood Cancer Taskforce

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

29

Aug

Immune infiltration 'promising tool' to improve outcomes for follicular lymphoma

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.

18

Jul

New score to help navigate improved treatment for follicular lymphoma patients

Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic approach for follicular lymphoma (FL).

10

Jun

Mater researcher investigates a new therapeutic approach for follicular lymphoma

Professor Maher Gandhi will be appointed as Chief Executive Officer of Mater Research and Director of MRI-UQ, effective May 1 2019.

24

Apr

Professor Maher Gandhi appointed Chief Executive Officer of Mater Research

Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.

18

Feb

$3.6 million awarded to develop treatment for relapsed lymphoma patients

Following an international search, Professor Maher Gandhi has been appointed Director of Clinical Research at Mater Research.

03

Oct

Mater Research announces appointment to Director of Clinical Research